Friday, 21 Sep 2018

TNF inhibitor

Datesort ascending Type Title Save
21 Aug 2018 Social TB Study of 550 RA, PsA, AS patients on TNF inhibitors from Romania (population risk is 97 per100k PY): incidence of TB on TNFi to be 1348.0, 862.1 and 540.2 per 100k Pt-Yrs (measured as TST >5, TST>10mm, QFT) https://t.co/SIkefJg909
03 Aug 2018 News Higher Infection Rates for Infliximab in Psoriasis
19 Jul 2018 News Biomarker Combo Predicts TNF Inhibitor Responses
12 Jun 2018 News TNF Inhibitors Don't Increase Cancer Risk in Children
11 Jun 2018 News Risk of Psoriasis Complicating TNF Inhibitor Therapy
09 Apr 2018 News Favorable Certolizumab Safety Profile in Pregnancy
05 Mar 2018 News Severe Stevens-Johnson and Toxic Epidermal Necrolysis Syndromes May Respond to Etanercept
20 Feb 2018 News Pediatric Use of TNF inhbitors Does Not Increase Malignancy Risk
20 Feb 2018 Social PANTS study:Personalized anti-TNF Therapy in Crohn Disease tests real-world eficacy, safety & immunogenicity of infliximab vs biosimilar CT- P13 vs adalimumab. Wk 54 remission rate was 40% INFX, 40% CTP13 & 34% in ADA; immunogenicity was 26%, 28%, 11% https://t.co/irhImH6ipP
12 Feb 2018 Social RT @uptoTate: Obesity as a predictor for poor TNFi response in IBD. Dr. U. Mahadevan #RWCS @RheumNow https://t.co/nmCljYcaqJ
10 Feb 2018 Social RT @uptoTate: Likelihood of achieving remission in patients who’ve failed one TNFi. Dr. M. Genovese #RWCS @RheumNow https://t.co/kFt0InT5q5
26 Jan 2018 Social RheumNow Wk in Review is up. Discussing MPO bronchiectasis, $$ biologics, comorbidity in myositis, secondary TNF failure & ADAbs. Listen here https://t.co/wmVyjrzOB1 Watch there https://t.co/32q2qojDZC
25 Jan 2018 News Obesity Outweighs Psoriasis in Comorbidity Risk with Children
25 Jan 2018 News Anti-Drug Antibodies Partly Explain Secondary TNF Inhibitor Failures
24 Jan 2018 News PRESERVE Study: HAQ, BMI and Age Predict Responses to Combo Therapy
12 Jan 2018 Social 188 PsA pts receive 1st TNFi, 27% D/C by 24 mos (1/3 for primary inefficacy, 22% secondary inefficacy, 43% adverse events) Predictors of failure = female or metabolic syndrome-co-morbidities (HR = 2.65). https://t.co/VRdikUSQ0f
08 Dec 2017 News Why TNF Inhibitors May Work in Some Autoinflammatory Patients
07 Dec 2017 News Infliximab Does Not Increase Perioperative Infection
21 Nov 2017 ACR Video Dr. Rachel Tate: Sarcoidosis and TNF Inhibitors
08 Nov 2017 Social RT @uptoTate: 84% of cardiac sarcoidosis pts refractory to immunosuppressive tx responded to TNFi. #ACR17 @RheumNow #2904 https://t.co/vTOL…